Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Immutep (IMMP)

NASDAQ:IMMP

IMMP

Immutep

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Immutep (IMMP) Stock News & Sentiment

574 Followers

Immutep’s Efti Shows Promise in Sarcoma Trial

PremiumCompany Announcements

Immutep’s Efti Shows Promise in Sarcoma Trial

12d ago

Immutep Shares Upbeat Clinical Trials Update

PremiumCompany Announcements

Immutep Shares Upbeat Clinical Trials Update

15d ago

Immutep’s Efti Shows Promise in Cancer Trial

PremiumCompany Announcements

Immutep’s Efti Shows Promise in Cancer Trial

20d ago

Immutep Advances Novel Autoimmune Therapy with Phase I Trial

PremiumCompany Announcements

Immutep Advances Novel Autoimmune Therapy with Phase I Trial

26d ago

Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

PremiumPress Releases

Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

5M ago

Immutep Receives A$2.6 million R&D Tax Incentive from French Government

PremiumPress Releases

Immutep Receives A$2.6 million R&D Tax Incentive from French Government

5M ago

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

PremiumPress Releases

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

6M ago

More IMMP News >

IMMP News on the Web

2024-05-02

Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma

Yahoo Finance

Neutral

2024-04-29

Immutep Quarterly Activities Report Q3 FY24

Yahoo Finance

Neutral

2024-04-26

Immutep’s Efti Shows Promise in Cancer Therapy, Analyst Maintains Buy Rating

TipRanks News

Bullish

2024-04-25

Immutep Buy Rating Justified by Strong Clinical Trial Results and Promising Future Prospects

TipRanks News

Bullish

2024-04-24

Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B

Yahoo Finance

Neutral

2024-04-18

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761

Yahoo Finance

Neutral

2024-04-17

Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

Yahoo Finance

Bullish

2024-03-24

11 Best ASX Stocks To Buy Now

Yahoo Finance

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMMP’s Media Buzz Sentiment?

Currently, no data Available

What is IMMP’s weekly average amount of articles?

Currently, no data Available

What is IMMP’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

MTDMettler-Toledo

SYRESpyre Therapeutics

CRNXCrinetics Pharmaceuticals

HAEHaemonetics

LEGNLegend Biotech

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing